Choline, mainly used to study parathyroid disease, and PSMA, to diagnose and monitor prostate cancer, are already routinely used in clinical practice, possibly increasing their chances of being implemented in ovarian cancer diagnostics. This evidence concerns the gene FOLH1 and ovarian cancer.